Thrombosis and Haemostasis

Issue 09 · 2012

Invited Editorial Focus
405
Skjøth, Flemming; Larsen, Torben Bjerregaard; Rasmussen, Lars Hvilsted:
Indirect comparison studies – are they useful? Insights from the novel oral anticoagulants for stroke prevention in atrial fibrillation

HTML

PDF (66 kb)
407
Harenberg, Job; Marx, Svetlana; Wehling, Martin:
Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: What’s next?

HTML

PDF (93 kb)
Current Controversies
410
Verheugt, Freek W. A.:
Outcomes of positive randomised controlled clinical trials: Double-blind or double vision?

HTML

PDF (64 kb)
412
Serebruany, Victor L.; Atar, Dan:
Viewpoint: Central adjudication of myocardial infarction in outcome-driven clinical trials – Common patterns in TRITON, RECORD, and PLATO?

HTML

PDF (83 kb)
T&H Insight
415
Preissner, Klaus T.:
Adipose tissue-derived PAI-1: A molecular link for thrombo-inflammatory disease states?

HTML

PDF (48 kb)
Theme Issue Editorial
416
Guzik, Tomasz J.; Dulak, Jozef:
Vessel wall – where coagulation meets cell biology and immunology

HTML

PDF (145 kb)
Theme Issue Article
419
Fish, Richard J.; Neerman-Arbez, Marguerite:
Fibrinogen gene regulation

HTML

PDF (222 kb)
427
Fish, Richard J.; Neerman-Arbez, Marguerite:
A novel regulatory element between the human FGA and FGG genes

HTML

PDF (305 kb)

Supplementary Material

Online Supplementary Material (PDF) (PDF)

Online Supplementary Material (PDF) (PDF)
435
Martin-Ventura, Jose Luis; Madrigal-Matute, Julio; Martinez-Pinna, Roxana; Ramos-Mozo, Priscila; Blanco-Colio, Luis Miguel; Moreno, Juan Antonio; Tarin, Carlos; Burillo, Elena; Fernandez-Garcia, Carlos Ernesto; Egido, Jesus; Meilhac, Olivier; Michel, Jean-Baptiste:
Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: Detoxifying mechanisms and potential therapeutic options

HTML

PDF (286 kb)
443
Matusik, Pawel; Guzik, Bartlomiej; Weber, Christian; Guzik, Tomasz J.:
Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice?

HTML

PDF (1559 kb)
457
Flierl, Ulrike; Schäfer, Andreas:
Fractalkine – a local inflammatory marker aggravating platelet activation at the vulnerable plaque

HTML

PDF (947 kb)
464
Wojakowski, Wojciech; Tendera, Michal; Cybulski, Wieslaw; Zuba-Surma, Ewa K.; Szade, Krzysztof; Florczyk, Urszula; Kozakowska, Magdalena; Szymula, Agnieszka; Krzych, Lukasz; Paslawska, Urszula; Paslawski, Robert; Milewski, Krzysztof; Buszman, Piotr P.; Nabialek, Edyta; Kuczmik, Waclaw; Janiszewski, Adrian; Dziegiel, Piotr; Buszman, Pawel E.; Józkowicz, Alicja; Dulak, Jozef:
Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on myocardial reperfusion injury

HTML

PDF (901 kb)
Review Article
476
Mantha, Simon; Ansell, Jack:
An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation

HTML

PDF (195 kb)
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
485
Ekström, Mattias; Liska, Jan; Eriksson, Per; Sverremark-Ekström, Eva; Tornvall, Per:
Stimulated in vivo synthesis of plasminogen activator inhibitor-1 in human adipose tissue

HTML

PDF (318 kb)
493
Kahn, Susan R.; Springmann, Vicky; Schulman, Sam; Martineau, Josée; Stewart, John A.; Komari, Nelly; McLeod, Anne; Strulovitch, Carla; Blostein, Mark; Faucher, Jacques-Philippe; Gamble, Greg; Gordon, Wendy; Kagoma, Peter K.; Miron, Marie-José; Laverdière, David; Game, Melaku; Mills, Allan:
Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting

HTML

PDF (199 kb)
499
Stuijver, Danka J. F.; Debeij, Jan; van Zaane, Bregje; Dekkers, Olaf M.; Smit, Jan W. A.; Büller, Harry R.; Rosendaal, Frits R.; Gerdes, Victor E. A.; Cannegieter, Suzanne C.:
Levels of prolactin in relation to coagulation factors and risk of venous thrombosis

HTML

PDF (519 kb)
508
Wattanakit, Keattiyoat; Lutsey, Pamela L.; Bell, Elizabeth J.; Gornik, Heather; Cushman, Mary; Heckbert, Susan R.; Rosamond, Wayne D.; Folsom, Aaron R.:
Association between cardiovascular disease risk factors and occurrence of venous thromboembolism

HTML

PDF (146 kb)
516
Marchi, Rita; Walton, Bethany L.; McGary, Colleen S.; Lin, Feng-Chang; Ma, Alice D.; Pawlinski, Rafal; Mackman, Nigel; Campbell, Robert A.; Di Paola, Jorge; Wolberg, Alisa S.:
Dysregulated coagulation associated with hypofibrinogenaemia and plasma hypercoagulability: Implications for identifying coagulopathic mechanisms in humans

HTML

PDF (602 kb)
527
Crescente, Marilena; Thomas, Grace M.; Demers, Melanie; Voorhees, Jaymie R.; Wong, Siu Ling; Ho-Tin-Noé, Benoit; Wagner, Denisa D.:
ADAMTS13 exerts a thrombolytic effect in microcirculation

HTML

PDF (193 kb)
Platelets and Blood Cells
533
Dragani, Alfredo; Falco, Angela; Santilli, Francesca; Basili, Stefania; Rolandi, Giancarlo; Cerasa, Loredana; Lattanzio, Stefano; Ciabattoni, Giovanni; Patrono, Carlo; Davì, Giovanni:
Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism

HTML

PDF (1073 kb)

Supplementary Material

Online Supplementary Material (PDF) (PDF)

Online Supplementary Material (PDF) (PDF)
Cardiovascular Biology and Cell Signalling
543
Van Hattum, Eline S.; Tangelder, Marco J. D.; Lawson, James A.; Moll, Frans L.; Algra, Ale:
Long-term risk of vascular events after peripheral bypass surgery

HTML

PDF (438 kb)
554
Hansen-Krone, Ida J.; Enga, Kristin F.; Njølstad, Inger; Hansen, John-Bjarne; Braekkan, Sigrid K.:
Heart healthy diet and risk of myocardial infarction and venous thromboembolism

HTML

PDF (137 kb)
New Technologies, Diagnostic Tools and Drugs
561
Borgman, Mark P.; Pendleton, Robert C.; McMillin, Gwendolyn A.; Reynolds, Kristen K.; Vazquez, Sara; Freeman, Andrew; Wilson, Andrew; Valdes, Roland; Linder, Mark W.:
Prospective pilot trial of PerMIT versus standard anticoagulation service management of patients initiating oral anticoagulation

HTML

PDF (213 kb)
570
Oliveira, Daniella Gorete Lourenço; Alvarez-Flores, Miryam Paola; Lopes, Adriana Rios; Chudzinski-Tavassi, Ana Marisa:
Functional characterisation of Vizottin, the first factor Xa inhibitor purified from the leech Haementeria vizottoi

HTML

PDF (363 kb)
Letters to the Editor
579
Stöllberger, Claudia; Rakusan, Stanislaus; Wimpissinger, Florian T.; Finsterer, Josef:
Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention

HTML

PDF (75 kb)
581
Skov, Jane; Leppin, Anja; Bladbjerg, Else-Marie; Sidelmann, Johannes J.; Gram, Jørgen:
Perceived stress predicts the stability of vitamin K-antagonist treatment of anticoagulant clinic patients

HTML

PDF (89 kb)
583
Louët, Agnès Lillo-Le; Wolf, Martine; Soufir, Lilia; Galbois, Arnaud; Dumenil, Anne-Sylvie; Offenstadt, Georges; Samama, Meyer-Michel:
Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: Implications for emergency surgery and resuscitation

HTML

PDF (86 kb)
586
Davis, Patrick K.; Musunuru, Harsha; Walsh, Mark; Mitra, Raman; Ploplis, Victoria; Castellino, Francis J.:
The ex vivo reversibility of dabigatran-induced whole-blood coagulopathy as monitored by thromboelastography: Mechanistic implications for clinical medicine

HTML

PDF (112 kb)

Archive
Free Sample Issue

Journal

Authors

Subscription

Collections

Social Media

Thrombosis and Haemostasis

Indirect comparison studies – are they useful? Insights from the novel oral anticoagulants for stroke prevention in atrial fibrillation

Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: What’s next?

Outcomes of positive randomised controlled clinical trials: Double-blind or double vision?

Viewpoint: Central adjudication of myocardial infarction in outcome-driven clinical trials – Common patterns in TRITON, RECORD, and PLATO?

Adipose tissue-derived PAI-1: A molecular link for thrombo-inflammatory disease states?

Vessel wall – where coagulation meets cell biology and immunology

Fibrinogen gene regulation

A novel regulatory element between the human FGA and FGG genes

Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: Detoxifying mechanisms and potential therapeutic options

Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice?

Fractalkine – a local inflammatory marker aggravating platelet activation at the vulnerable plaque

Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on myocardial reperfusion injury

An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation

Stimulated in vivo synthesis of plasminogen activator inhibitor-1 in human adipose tissue

Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting

Levels of prolactin in relation to coagulation factors and risk of venous thrombosis

Association between cardiovascular disease risk factors and occurrence of venous thromboembolism

Dysregulated coagulation associated with hypofibrinogenaemia and plasma hypercoagulability: Implications for identifying coagulopathic mechanisms in humans

ADAMTS13 exerts a thrombolytic effect in microcirculation

Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism

Long-term risk of vascular events after peripheral bypass surgery

Heart healthy diet and risk of myocardial infarction and venous thromboembolism

Prospective pilot trial of PerMIT versus standard anticoagulation service management of patients initiating oral anticoagulation

Functional characterisation of Vizottin, the first factor Xa inhibitor purified from the leech Haementeria vizottoi

Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention

Perceived stress predicts the stability of vitamin K-antagonist treatment of anticoagulant clinic patients

Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: Implications for emergency surgery and resuscitation

The ex vivo reversibility of dabigatran-induced whole-blood coagulopathy as monitored by thromboelastography: Mechanistic implications for clinical medicine